• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管生成素-1的失调在脑型疟疾的发病机制中起作用。

Dysregulation of angiopoietin-1 plays a mechanistic role in the pathogenesis of cerebral malaria.

作者信息

Higgins Sarah J, Purcell Lisa A, Silver Karlee L, Tran Vanessa, Crowley Valerie, Hawkes Michael, Conroy Andrea L, Opoka Robert O, Hay John G, Quaggin Susan E, Thurston Gavin, Liles W Conrad, Kain Kevin C

机构信息

Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario M5S 1A8, Canada. Sandra Rotman Centre for Global Health, University Health Network-Toronto General Hospital, and the Tropical Disease Unit, Department of Medicine, University of Toronto, Toronto, Ontario M5G 1L7, Canada. Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.

Regeneron Pharmaceuticals Inc, Tarrytown, NY 10591, USA.

出版信息

Sci Transl Med. 2016 Sep 28;8(358):358ra128. doi: 10.1126/scitranslmed.aaf6812.

DOI:10.1126/scitranslmed.aaf6812
PMID:27683553
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6450386/
Abstract

Cerebral malaria is a leading cause of global morbidity and mortality. Interventions targeting the underlying pathophysiology of cerebral malaria may improve outcomes compared to treatment with antimalarials alone. Microvascular leak plays an important role in the pathogenesis of cerebral malaria. The angiopoietin (Ang)-Tie-2 system is a critical regulator of vascular function. We show that Ang-1 expression and soluble Tie-2 expression were associated with disease severity and outcome in a prospective study of Ugandan children with severe malaria and in a preclinical murine model of experimental cerebral malaria. Ang-1 was necessary for maintenance of vascular integrity and survival in a mouse model of cerebral malaria. Therapeutic administration of Ang-1 preserved blood-brain barrier integrity and, in combination with artesunate treatment, improved survival beyond that with artesunate alone. These data define a role for dysregulation of the Ang-Tie-2 axis in the pathogenesis of cerebral malaria and support the evaluation of Ang-Tie-2-based interventions as potential adjunctive therapies for treating severe malaria.

摘要

脑型疟疾是全球发病和死亡的主要原因。与仅用抗疟药治疗相比,针对脑型疟疾潜在病理生理学的干预措施可能会改善治疗结果。微血管渗漏在脑型疟疾的发病机制中起重要作用。血管生成素(Ang)-Tie-2系统是血管功能的关键调节因子。我们在一项对乌干达重症疟疾儿童的前瞻性研究以及实验性脑型疟疾的临床前小鼠模型中表明,Ang-1表达和可溶性Tie-2表达与疾病严重程度和预后相关。在脑型疟疾小鼠模型中,Ang-1是维持血管完整性和生存所必需的。Ang-1的治疗性给药可保持血脑屏障的完整性,并且与青蒿琥酯联合治疗相比单独使用青蒿琥酯可提高生存率。这些数据确定了Ang-Tie-2轴失调在脑型疟疾发病机制中的作用,并支持评估基于Ang-Tie-2的干预措施作为治疗重症疟疾的潜在辅助疗法。

相似文献

1
Dysregulation of angiopoietin-1 plays a mechanistic role in the pathogenesis of cerebral malaria.血管生成素-1的失调在脑型疟疾的发病机制中起作用。
Sci Transl Med. 2016 Sep 28;8(358):358ra128. doi: 10.1126/scitranslmed.aaf6812.
2
Endothelial activation and dysregulation in malaria: a potential target for novel therapeutics.疟疾中的内皮细胞激活和失调:新型治疗药物的潜在靶点。
Curr Opin Hematol. 2011 May;18(3):177-85. doi: 10.1097/MOH.0b013e328345a4cf.
3
Artesunate and erythropoietin synergistically improve the outcome of experimental cerebral malaria.青蒿琥酯与促红细胞生成素协同改善实验性脑型疟疾的预后。
Int Immunopharmacol. 2017 Jul;48:219-230. doi: 10.1016/j.intimp.2017.05.008. Epub 2017 May 19.
4
S1P is associated with protection in human and experimental cerebral malaria.S1P 与人类和实验性脑疟疾的保护有关。
Mol Med. 2011;17(7-8):717-25. doi: 10.2119/molmed.2010.00214. Epub 2011 May 5.
5
Efficacy and safety evaluation of a novel trioxaquine in the management of cerebral malaria in a mouse model.新型三氧喹啉治疗小鼠脑型疟疾的疗效与安全性评估
Malar J. 2017 Jul 3;16(1):268. doi: 10.1186/s12936-017-1917-6.
6
Inhaled nitric oxide reduces endothelial activation and parasite accumulation in the brain, and enhances survival in experimental cerebral malaria.吸入一氧化氮可减少脑内皮细胞的激活和寄生虫的积聚,并提高实验性脑疟疾的存活率。
PLoS One. 2011;6(11):e27714. doi: 10.1371/journal.pone.0027714. Epub 2011 Nov 16.
7
A clinicopathological correlation of the expression of the angiopoietin-Tie-2 receptor pathway in the brain of adults with Plasmodium falciparum malaria.成人恶性疟原虫疟疾脑中血管生成素-Tie-2 受体通路表达的临床病理相关性。
Malar J. 2013 Feb 5;12:50. doi: 10.1186/1475-2875-12-50.
8
Pharmacologic inhibition of CXCL10 in combination with anti-malarial therapy eliminates mortality associated with murine model of cerebral malaria.药物抑制 CXCL10 联合抗疟治疗消除了与脑型疟疾小鼠模型相关的死亡率。
PLoS One. 2013 Apr 5;8(4):e60898. doi: 10.1371/journal.pone.0060898. Print 2013.
9
Advanced Glycation End-Products and Hyperglycemia Increase Angiopoietin-2 Production by Impairing Angiopoietin-1-Tie-2 System.晚期糖基化终产物和高血糖通过损害血管生成素 1-血管生成素受体 2 系统增加血管生成素 2 的产生。
J Diabetes Res. 2019 Nov 11;2019:6198495. doi: 10.1155/2019/6198495. eCollection 2019.
10
Serum angiopoietin-1 and -2 levels discriminate cerebral malaria from uncomplicated malaria and predict clinical outcome in African children.血清血管生成素-1和-2水平可区分脑型疟疾与非重症疟疾,并能预测非洲儿童的临床结局。
PLoS One. 2009;4(3):e4912. doi: 10.1371/journal.pone.0004912. Epub 2009 Mar 20.

引用本文的文献

1
Latest updates on pathogenesis mechanisms and management strategies for cytokine release syndrome, neurotoxicity, and hemophagocytic lymphohistiocytosis related to CAR-T cell therapies.嵌合抗原受体T细胞(CAR-T)疗法相关的细胞因子释放综合征、神经毒性和噬血细胞性淋巴组织细胞增生症的发病机制及管理策略的最新进展
Ann Hematol. 2025 Jun 19. doi: 10.1007/s00277-025-06467-y.
2
Host biomarkers and parasite biomass are associated with severe malaria in Mozambican children: a case-control study.宿主生物标志物和疟原虫生物量与莫桑比克儿童的重症疟疾相关:一项病例对照研究。
Sci Rep. 2025 Apr 24;15(1):14262. doi: 10.1038/s41598-025-98154-1.
3
Dual nature of type I interferon responses and feedback regulations by SOCS1 dictate malaria mortality.

本文引用的文献

1
Gene control of tyrosine kinase TIE2 and vascular manifestations of infections.酪氨酸激酶TIE2的基因调控与感染的血管表现
Proc Natl Acad Sci U S A. 2016 Mar 1;113(9):2472-7. doi: 10.1073/pnas.1519467113. Epub 2016 Feb 16.
2
Global and National Burden of Diseases and Injuries Among Children and Adolescents Between 1990 and 2013: Findings From the Global Burden of Disease 2013 Study.1990年至2013年间全球及各国儿童和青少年的疾病与伤害负担:全球疾病负担研究2013的结果
JAMA Pediatr. 2016 Mar;170(3):267-87. doi: 10.1001/jamapediatrics.2015.4276.
3
Brain swelling and death in children with cerebral malaria.
I型干扰素反应的双重性质以及SOCS1的反馈调节决定了疟疾死亡率。
J Adv Res. 2025 Jul;73:295-310. doi: 10.1016/j.jare.2024.08.027. Epub 2024 Aug 22.
4
Exploring adjunctive therapies for cerebral malaria.探索脑型疟疾的辅助疗法。
Front Cell Infect Microbiol. 2024 Feb 12;14:1347486. doi: 10.3389/fcimb.2024.1347486. eCollection 2024.
5
The Mechanisms of Altered Blood-Brain Barrier Permeability in CD19 CAR T-Cell Recipients.CD19 CAR T 细胞受者血脑屏障通透性改变的机制。
Int J Mol Sci. 2024 Jan 4;25(1):644. doi: 10.3390/ijms25010644.
6
Unravelling mysteries at the perivascular space: a new rationale for cerebral malaria pathogenesis.解析血管周围腔室之谜:脑型疟疾发病机制的新理论依据。
Trends Parasitol. 2024 Jan;40(1):28-44. doi: 10.1016/j.pt.2023.11.005. Epub 2023 Dec 8.
7
Calcium sulfate-Cu delivery system improves 3D-Printed calcium silicate artificial bone to repair large bone defects.硫酸钙-铜输送系统改善3D打印硅酸钙人工骨修复大骨缺损的效果。
Front Bioeng Biotechnol. 2023 Oct 25;11:1224557. doi: 10.3389/fbioe.2023.1224557. eCollection 2023.
8
Pathogenetic mechanisms and treatment targets in cerebral malaria.脑型疟疾的发病机制与治疗靶点
Nat Rev Neurol. 2023 Nov;19(11):688-709. doi: 10.1038/s41582-023-00881-4. Epub 2023 Oct 19.
9
MICROVASCULAR ENDOTHELIAL ACTIVATION/DYSFUNCTION AND DYSREGULATION OF THE ANGIOPOIETIN-TIE2 SYSTEM IN THE PATHOGENESIS OF LIFE-THREATENING INFECTIONS.微血管内皮细胞的激活/功能障碍与血管生成素-Tie2 系统失调在危及生命的感染发病机制中的作用。
Trans Am Clin Climatol Assoc. 2023;133:234-246.
10
Diagnosis of cerebral malaria: Tools to reduce associated mortality.脑型疟疾的诊断:降低相关死亡率的工具。
Front Cell Infect Microbiol. 2023 Feb 9;13:1090013. doi: 10.3389/fcimb.2023.1090013. eCollection 2023.
脑肿胀和死亡的儿童与脑疟疾。
N Engl J Med. 2015 Mar 19;372(12):1126-37. doi: 10.1056/NEJMoa1400116.
4
Host genetic diversity enables Ebola hemorrhagic fever pathogenesis and resistance.宿主基因多样性影响埃博拉出血热的发病机制及抵抗力。
Science. 2014 Nov 21;346(6212):987-91. doi: 10.1126/science.1259595. Epub 2014 Oct 30.
5
Development, maintenance and disruption of the blood-brain barrier.血脑屏障的发育、维持和破坏。
Nat Med. 2013 Dec;19(12):1584-96. doi: 10.1038/nm.3407. Epub 2013 Dec 5.
6
Piecing together the puzzle of severe malaria.解析严重疟疾之谜。
Sci Transl Med. 2013 Nov 13;5(211):211ps18. doi: 10.1126/scitranslmed.3007432.
7
Platelet activation determines angiopoietin-1 and VEGF levels in malaria: implications for their use as biomarkers.血小板活化决定疟疾中血管生成素-1和血管内皮生长因子水平:对其作为生物标志物应用的启示
PLoS One. 2013 Jun 3;8(6):e64850. doi: 10.1371/journal.pone.0064850. Print 2014.
8
Dysregulation of the angiopoietin-Tie-2 axis in sepsis and ARDS.脓毒症和 ARDS 中血管生成素-Tie-2 轴的失调。
Virulence. 2013 Aug 15;4(6):517-24. doi: 10.4161/viru.24906. Epub 2013 May 7.
9
Malaria biology and disease pathogenesis: insights for new treatments.疟疾生物学和发病机制:新疗法的启示。
Nat Med. 2013 Feb;19(2):156-67. doi: 10.1038/nm.3073. Epub 2013 Feb 6.
10
Angiopoietin-2 functions as a Tie2 agonist in tumor models, where it limits the effects of VEGF inhibition.血管生成素-2 在肿瘤模型中作为 Tie2 激动剂发挥作用,限制了 VEGF 抑制的效果。
Cancer Res. 2013 Jan 1;73(1):108-18. doi: 10.1158/0008-5472.CAN-12-2064. Epub 2012 Nov 13.